Krishnan Rajesh 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Krishnan Rajesh
Chief Technology Officer
Transactions
- Tax Payment
Common Stock
2024-01-03$0.50/sh−11,838$5,873→ 44,019 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.